All articles
Category:
Disease

Cytomegalovirus (CMV) in Pregnancy

8 Sept 2026 · 19 min read

Cytomegalovirus (CMV) in Pregnancy
On this page13 sections

Cytomegalovirus (CMV) is a widespread, typically harmless virus that remains dormant in the body for life after an initial infection. In healthy individuals, it rarely causes symptoms. However, contracting CMV during pregnancy poses potential medical concerns because the virus can pass across the placenta to the developing fetus. This transmission is known as congenital CMV.

In Ireland, out of approximately 60,000 annual births, between 150 and 450 infants are born with congenital CMV. While the vast majority of these babies experience no long-term health complications, a small percentage may develop health issues.

CMV 1.png

Understanding the Types of Infection

An active CMV status during pregnancy falls into one of three clinical categories:

  • Primary CMV: The individual contracts the virus for the very first time.

  • CMV Reactivation: A previous, dormant infection becomes active again due to shifts in immune status.

  • CMV Reinfection: The individual is exposed to a completely different strain of the virus.

Identifying Symptoms

  • In healthy adults: Most infections are entirely asymptomatic. If symptoms do emerge, they mirror a mild flu (fever, fatigue, body aches) and typically resolve independently within 3 weeks.

  • In immunocompromised individuals: A CMV infection can cause a much wider, more severe spectrum of systemic symptoms.

  • In newborns (Congenital CMV): Clinical presentations at birth can range widely from completely unnoticeable (asymptomatic) to severe clinical complications.

How the Virus Spreads

CMV replicates within human bodily fluids, including saliva, urine, faeces, blood, tears, semen, vaginal secretions, and breast milk.

  • The Role of Young Children: Toddlers and preschool-aged children are the primary vectors for spreading CMV, as they frequently shed the virus in their saliva and urine. Consequently, individuals who already have young families or who work in childcare environments face the highest risk of exposure.

  • Breastfeeding Guidance: While CMV can be present in breast milk, passing the virus to a newborn through nursing is not classified as congenital CMV and does not carry the same developmental risks. The nutritional and immunological advantages of breastfeeding significantly outweigh the minimal risks associated with postnatal CMV exposure.

Diagnostic Testing Protocols

Routine universal screening for CMV is not standard practice during pregnancy, but targeted testing can be utilized if exposure is suspected:

  • Maternal Blood Tests: A dedicated blood draw can confirm if a pregnant individual has an active or past CMV infection. However, this test cannot definitively determine exactly when the infection was contracted, nor can it confirm if the virus has reached the fetus.

  • Amniocentesis: This invasive prenatal test is not routine. It is exclusively ordered if a fetal ultrasound reveals specific structural anomalies that strongly suggest a congenital CMV infection.

  • Neonatal Testing: Newborns suspected of having the virus are evaluated using targeted urine and blood samples collected shortly after birth.

Current Treatment Realities

  • During Pregnancy: There are currently no clinically recommended medical treatments to stop or cure a congenital CMV infection while the fetus is still in the womb.

  • Postnatal Care: If a newborn is diagnosed with symptomatic congenital CMV, medical treatments are customized entirely based on the specific symptoms and clinical severity the baby exhibits.

Proactive Prevention Strategies

Because there is no vaccine, pregnant individuals—or those planning a pregnancy—should practice strict behavioral hygiene to minimize exposure to young children's bodily fluids:

  • Hand Hygiene: Wash hands thoroughly with soap and warm water immediately after changing nappies, wiping runny noses, or handling feeding utensils. Always carry an alcohol-based hand sanitiser.

  • Avoid Fluid Contact: Do not share food, drinks, cutlery, or soothers with toddlers. When kissing young children, avoid contact with saliva (kiss on the forehead or head instead).

  • Sanitation: Regularly wash toys, play surfaces, or any objects that frequently come into contact with a child’s saliva or urine. Avoid touching your eyes, nose, or mouth until your hands are fully washed.

CMV  in Pregnancy

When a person is pregnant, an active cytomegalovirus (CMV) status falls into one of three distinct clinical categories based on their immunological history with the virus:

  • Primary CMV Infection: This occurs when a person contracts CMV for the very first time in their life. Because the body has no pre-existing antibodies, this type of infection carries the highest statistical risk of transmitting severe developmental complications to the fetus.

  • CMV Reactivation: This happens when a previous, dormant CMV infection already inside the body becomes active again. This is often triggered by natural shifts in immune function during pregnancy.

  • CMV Reinfection: This occurs when a person who has previously had CMV is exposed to, and infected by, a completely different strain of the virus.

Congenital CMV in Unborn and Newborn Babies

If the virus successfully crosses the placenta during any of these three stages, the baby develops what is known as congenital CMV.

While all three types of maternal CMV infections can potentially pass to the fetus, a primary CMV infection during pregnancy carries the greatest threat of causing severe, long-term health and neurological issues for the baby.

Maternal CMV Symptoms in Healthy Individuals

In individuals with a robust immune system, a cytomegalovirus (CMV) infection is usually entirely asymptomatic. If clinical symptoms do manifest, they generally mimic a mild flu, presenting a low health risk to the pregnant individual and resolving naturally within 3 weeks.

📞 When to Contact Your GP

If you are pregnant, schedule a non-urgent GP appointment if you experience any flu-like symptoms, including:

  • A fever reaching 38°C (100.4°F) or above.

  • Persistent, unexplained fatigue or general malaise.

  • A sore throat.

  • Swollen lymph nodes (glands).

  • Generalized body aches and pains.

  • Profuse night sweats.

CMV Symptoms in Immunocompromised Individuals

A weakened immune system can be caused by HIV, organ or bone marrow transplants, or medical therapies for cancer and autoimmune conditions (such as rheumatoid arthritis, lupus, multiple sclerosis, or inflammatory bowel disease). In these cases, a primary or reactivated CMV infection can cause severe, systemic complications.

Critical Complications & Signs:

  • Gastrointestinal: Persistent diarrhoea and large, painful ulcers developing in the mouth or oesophagus (gullet).

  • Ocular (Retinitis): Blurred vision, blind spots, or "floaters" (dark specks or squiggly lines in your field of vision), which can indicate inflammation at the back of the eye.

  • Respiratory (Pneumonia): A persistent cough, acute shortness of breath, or sharp chest pain.

  • Systemic: A persistent temperature of 38°C (100.4°F) or above.

Neonatal Symptoms of Congenital CMV at Birth

In Ireland, between 150 and 450 babies are born with congenital CMV annually. While most remain healthy, the infection can occasionally lead to miscarriage, premature delivery, or stillbirth.

Infants born with symptomatic congenital CMV may display mild-to-severe clinical signs at birth. Note: Many of these signs are common in newborns and do not automatically confirm a CMV diagnosis.

Signs Visible at Birth:

  • Jaundice: Yellowing of the skin and eyes.

  • Growth Issues: A notably low birth weight or microcephaly (the baby's head is significantly smaller than expected).

  • Skin Anomalies: A distinct rash, particularly one featuring small, purplish spots.

  • Organ Dysfunction: An enlarged liver or pneumonia.

  • Neurological Issues: Seizures, fits, or involuntary convulsions.

Long-Term Developmental Complications

Infants who present with noticeable symptoms of CMV at birth carry a significantly higher statistical risk of developing moderate-to-severe, long-term health and developmental challenges. Because congenital CMV targets the central nervous system (the brain and spinal cord), it can lead to permanent damage.

Potential Long-Term Problems:

  • Sensory Deficits: Progressive hearing loss, visual impairment, or total blindness.

  • Cognitive Delay: Learning difficulties, intellectual delays, or speech and language impairments.

  • Motor Dysfunction: Cerebral palsy (impaired movement, coordination, and muscle tone) or secondary motor deficits.

  • Neurological Disorders: Chronic epilepsy.

Specialized Newborn Medical Screening

Every infant born in Ireland undergoes a standard battery of routine neonatal checks. However, if a newborn is diagnosed with congenital CMV, the medical team will immediately order three specialized diagnostic assessments to map the virus's impact on the central nervous system:

CMV 2.png

Causes

Cytomegalovirus (CMV) is transmitted through direct contact with infected bodily fluids, including saliva, urine, faeces, blood, tears, semen, vaginal secretions, and breast milk.

Understanding how the virus spreads, when it is active, and who is most vulnerable can help you lower transmission risks during pregnancy.

Transmission Realities & High-Risk Settings

The risk of contracting CMV through casual contact—such as shaking hands, having a conversation, or using public transport—is extremely low. Instead, the virus is primarily driven by close, prolonged contact with specific high-risk vectors.

  • The Primary Vectors: Healthy toddlers and preschool-aged children are the most common source of CMV transmission. While the virus rarely causes serious illness in the children themselves, they frequently shed high viral loads in their saliva and urine.

  • Elevated Risk Categories: You face a significantly higher statistical risk of catching CMV if you work in childcare environments (like crèches or schools) or if you already have a young family at home.

  • Breastfeeding Safety: Although CMV can be present in breast milk, passing the virus to a newborn through nursing is not classified as congenital CMV. Postnatal exposure through breast milk does not cause the same developmental issues as pre-birth transmission. The extensive nutritional and immunological benefits of breastfeeding far outweigh the minimal risks associated with postnatal exposure. 

When and How Long is CMV Contagious?

CMV can only be transmitted when the virus is actively replicating inside the body and shedding into bodily fluids (most notably saliva and urine). Because the virus is usually asymptomatic in healthy individuals, most people shed the virus without knowing they are contagious.

The virus enters an active state under three specific conditions:

  1. Primary Infection: Contracting the virus for the very first time.

  2. Reactivation: A dormant, lifelong infection waking up again.

  3. Reinfection: Becoming infected with a completely different strain of the virus.

Duration of Active Shedding:

  • In Adults: After a new or reactivated infection, the virus generally remains active and transmissible for a period of weeks to months.

  • In Infants: Babies born with congenital CMV, or those who contract the virus in their first years of life, can shed the active virus for a significantly longer duration, lasting from months to years.

Transmission Probabilities to the Fetus

If you contract an active form of CMV while pregnant, the statistical probability of the virus crossing the placenta to infect your unborn baby depends entirely on your prior immunity:

CMV 3.png

Basic Prevention & Clinical Guidance

If you are pregnant, planning a pregnancy, or have a weakened immune system, strict hygiene practices are your primary defense against CMV:

  • Targeted Handwashing: Thoroughly scrub your hands with soap and warm water before eating, and immediately after changing nappies, feeding a child, or tidying away toys. Always carry an alcohol-based hand sanitiser when out.

  • Fluid Avoidance: Never share food, cups, cutlery, or soothers with young children, and avoid getting their saliva in your mouth.

  • Clinical Consulting: If you are concerned about your personal risk, consult your GP, obstetrician, or midwife. They can assess your situation and order a maternal blood test to check your CMV status.

Diagnosing cytomegalovirus (CMV) during pregnancy

Diagnosing cytomegalovirus (CMV) during pregnancy involves a stepped approach, moving from maternal blood tests to advanced fetal imaging and specialized testing if a transmission is suspected. 

Step 1: Initial Maternal Screening

A maternal blood test can successfully diagnose whether a pregnant person has an active or past CMV infection. However, this test has clear clinical limitations:

  • It cannot always pinpoint the exact timeline or date when the infection occurred.

  • It cannot diagnose whether the virus has successfully crossed the placenta to infect the unborn baby.

Note: If you have concerns about potential exposure, discuss your risk directly with your GP, obstetrician, or midwife to evaluate if a blood test is appropriate for you.

Step 2: Fetal Surveillance (Ultrasound)

A routine fetal anatomy ultrasound scan serves as the primary, non-invasive way to monitor fetal health. This scan can sometimes detect structural markers or anomalies that indicate a congenital CMV infection—most notably if it reveals that the baby’s brain is not developing as expected.

Step 3: Prenatal Diagnostic Testing (Amniocentesis)

If an ultrasound scan highlights potential markers for congenital CMV, a diagnostic procedure called an amniocentesismay be offered.

What to Know About Amniocentesis for CMV:

  • The Procedure: A specialist inserts a fine needle through the abdomen to collect a sample of amniotic fluid (the protective fluid surrounding the baby in the womb) to test directly for the virus.

  • The Limitations: While this test can confirm or rule out the presence of the virus in the womb, it cannot predicthow severe the effects will be or what specific long-term health issues the baby might develop.

  • The Risks: Amniocentesis is an invasive procedure that carries a 1% risk of miscarriage.

  • The Cost: If clinically indicated, this test is fully covered as a standard part of your public antenatal care; there is no out-of-pocket fee.

Step 4: Postnatal Testing for Newborns

Testing for CMV at birth is not a universal or routine screening. Instead, targeted diagnostic testing using neonatal urine and blood samples will be performed shortly after delivery if the care team has pre-existing concerns or if the mother had a confirmed infection during pregnancy.

Prevention

Reducing your risk of catching cytomegalovirus (CMV) is crucial if you are currently pregnant or planning a pregnancy. Because young children are the primary carriers of the virus, practicing strict hygiene around toddlers and preschool-aged children is your best defense.

Essential Hygiene Practices

  • Targeted Handwashing: Wash your hands thoroughly with soap and warm water. Do this immediately after changing nappies, feeding a child, or wiping a child's nose, and always before you eat.

  • Avoid Fluid Sharing: Do not share food, drinks, cutlery, cups, or soothers with young children.

  • Safe Affection: Avoid contact with a child’s saliva when kissing them. Kiss them on the forehead or the top of the head instead of the lips or cheeks.

  • Surface Sanitation: Regularly wash toys, high chairs, and any other items that frequently come into contact with a child's saliva or urine.

Environmental Persistence of the Virus

Understanding how CMV behaves on everyday items can help you target your cleaning habits effectively:

[ CMV Exposure on Surfaces ]

      │

      ├─► Can survive outside the body for up to 6 hours.

      │

      └─► Survival rate spikes on wet, absorbent materials

          (e.g., damp tea towels, sponges, or washcloths).

Proactive Protection Checklist

  • Carry Sanitiser: Always keep an alcohol-based hand sanitiser with you for times when soap and water are unavailable.

  • Break the Habit: Avoid touching your eyes, nose, or mouth, especially if you have recently handled children's items or have potential bodily fluids on your hands.

  • Rotate Linens: Frequently change out hand towels and kitchen cloths to ensure you are not leaving damp surfaces where the virus can live.

If you have recently been diagnosed with a primary cytomegalovirus (CMV) infection, clinical guidelines generally recommend delaying pregnancy for 12 months from the time of diagnosis. This waiting period allows the active phase of the virus to pass, significantly reducing the risk of transmitting the virus across the placenta to a developing fetus.

Balancing Medical Advice with Personal Timelines

Delaying a pregnancy for a full year is not always feasible or preferred due to a variety of personal factors, including maternal age or fertility considerations.

If a 12-month delay presents challenges for you:

  • Consult Your Care Team: Speak openly with your GP, obstetrician, or midwife. They can assess your individual health profile and discuss the specific medical risks associated with both your infection timeline and the potential impacts of delaying conception.

  • Make an Informed Choice: Reviewing these factors with your healthcare provider will give you the comprehensive information required to choose the path that best supports you and your family.

Monitoring and Clinical Next Steps

If you are currently trying to conceive and are concerned about your CMV status, your doctor can order a targeted maternal blood test to check your antibody levels. This test helps determine whether the initial infection has cleared and if it is safe to proceed with your pregnancy plans. 

Treatment in Pregnancy

Clinical Interventions During Pregnancy

Currently, there is no universally standard or approved cure for a congenital cytomegalovirus (CMV) infection during pregnancy. However, if a maternal CMV infection is confirmed, hospital specialists will carefully review the case to determine if maternal antiviral therapy is appropriate. While not a definitive cure, administering these antiviral medications to the pregnant person may offer protective benefits to the developing fetus.

Fortunately, in the vast majority of cases, the virus does not cause any long-term health or developmental problems for the baby.

Pediatric Treatment Protocols for Newborns

If a infant is born with congenital CMV, the neonatal care team will tailor their treatment strategy based on whether the baby is symptomatic or asymptomatic.

CMV 5.png

1. Management for Symptomatic Infants

Newborns who exhibit clear signs that the virus has impacted their central nervous system (brain and spinal cord) or other vital organs will be treated with specialized antiviral drugs to slow viral replication.

Targeted antiviral therapy is initiated if the infant presents with:

  • Neurological Signs: Microcephaly (an abnormally small head), seizures, or structural brain anomalies.

  • Sensory Impairments: Confirmed hearing loss or active eye problems (such as retinitis).

  • Organ Dysfunction: Severe, acute complications affecting the liver or lungs.

2. Management for Mild or Asymptomatic Infants

Medical antiviral therapy is not offered to newborns who are born with no obvious symptoms, or those who exhibit only mild, isolated symptoms that do not involve the central nervous system or vital organs. The potential side effects of antiviral medications outweigh the benefits for these infants, so they are monitored closely instead.

Critical Focus: Hearing Loss and Monitoring

Congenital CMV stands as the most common non-genetic cause of permanent hearing loss and deafness in children. Because this hearing loss can be progressive or delayed in onset, careful tracking is required:

  • Initial Screening: Every newborn baby undergoes a routine newborn hearing screening test shortly after birth.

  • Diagnostic Audiology: If the initial screen raises concerns or if congenital CMV is confirmed, the baby will be referred for advanced audiology tests.

  • Long-Term Follow-up: Affected infants will receive a structured schedule of follow-up audiology appointments throughout early childhood to catch and manage any late-developing hearing issues early.

Disclaimer

The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.